1Associate Professor of Orthopaedic Surgery, Department of Orthopaedic Surgery, The Johns Hopkins University, Baltimore, MD, USA
A. S. Levin ✉, Department of Orthopaedic Surgery, The Johns Hopkins University, 601 North Caroline Street, Baltimore, MD 21287, USA, Email: [email protected]
This CORR Insights® is a commentary on the article “Does PARP Inhibition Sensitize Chondrosarcoma Cell Lines to Chemotherapy or Radiotherapy? Results From a Three-dimensional Spheroid Cell Model” by Palubeckaité and colleagues available at: DOI: 10.1097/CORR.0000000000002483.
The author certifies that there are no funding or commercial associations (consultancies, stock ownership, equity interest, patent/licensing arrangements, etc.) that might pose a conflict of interest in connection with the submitted article related to the author or any immediate family members.
All ICMJE Conflict of Interest Forms for authors and Clinical Orthopaedics and Related Research® editors and board members are on file with the publication and can be viewed on request.
The opinions expressed are those of the writer, and do not reflect the opinion or policy of CORR® or The Association of Bone and Joint Surgeons®.
